Paul Rubin, Jacob W. Stahl, and Melissa Runsten

Paul Rubin is partner at Debevoise & Plimpton and co-chair of the firm’s Healthcare & Life Sciences Group. Jacob W. Stahl is counsel in Debevoise & Plimpton’s New York office and a member of the firm’s Litigation Department. Melissa Runsten is a corporate associate at the firm and a member of the Healthcare & Life Sciences Group.

Articles by Paul Rubin, Jacob W. Stahl, and Melissa Runsten

The American Rescue Plan Act of 2021: Pharmaceutical Industry Impact

ByPaul Rubin, Jacob W. Stahl, and Melissa Runsten

Published: March 23rd 2021 | Updated: January 6th 2023

Assessing the implications for the pharma industry of the America Rescue Plan Act of 2021, which provides nearly two trillion dollars in funding for various government programs, including many related to public health.

Latest Updated Articles

The American Rescue Plan Act of 2021: Pharmaceutical Industry Impact
Published: March 23rd 2021 | Updated: January 6th 2023

Paul Rubin, Jacob W. Stahl, and Melissa Runsten

Articles by Paul Rubin, Jacob W. Stahl, and Melissa Runsten

The American Rescue Plan Act of 2021: Pharmaceutical Industry Impact

Latest Updated Articles

Trending on PharmExec

Patent Term Extension: Challenges with Defining and Claiming Approved Biologics

Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion

Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site

The Multi-Purpose Paradigm: Scaling AI ROI and De-Risking the Life Sciences Value Chain

Bavarian Nordic’s CEO Paul Chaplin Set to Step Down